Rotigotine transdermal systems in a multicenter trial of patients with advanced-stage Parkinson's disease as adjunctive therapy to levodopa

被引：0
|
作者：
LeWitt, P
Nausieda, P
Chang, FL
Fazzini, E
Truong, D
Carpenter, M
Sommerville, K
Boroojerdi, B
机构：
来源：
NEUROLOGY | 2006年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A184 / A185
页数：2
相关论文
共 50 条
  • [21] Safety and tolerability of transdermal rotigotine in early-stage Parkinson's disease
    Tagliati, M.
    Watts, R. L.
    Patton, J.
    Poewe, W.
    Boroojerdi, B.
    MOVEMENT DISORDERS, 2006, 21 (09) : 1551 - 1551
  • [22] Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients
    Cassani, Erica
    Cancello, Raffaella
    Cavanna, Ferruccio
    Maestrini, Sabrina
    Di Blasio, Anna Maria
    Liuzzi, Antonio
    Pezzoli, Gianni
    Barichella, Michela
    PARKINSONS DISEASE, 2011, 2011
  • [23] Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Nomoto, Masahiro
    Mizuno, Yoshikuni
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 1887 - 1893
  • [24] Body composition in advanced-stage Parkinson’s disease
    M. L. Petroni
    G. Albani
    V. Bicchiega
    S. Baudo
    C. Vinci
    A. Montesano
    G. Izzo
    P. Bertocco
    S. Mazzotta
    E. Zorzetto
    F. Balzola
    A. Mauro
    Acta Diabetologica, 2003, 40 : s187 - s190
  • [25] Rotigotine CDS patch in advanced-stage, idiopathic Parkinson's disease: A parallel group, open-label, dose-escalation trial
    Babic, T
    Boroojerdi, B
    Randerath, O
    Poole, K
    Sommerville, KW
    NEUROLOGY, 2004, 62 (07) : A399 - A399
  • [26] Treatment of patients with early and advanced Parkinson's disease with transdermal rotigotine: age relationship to safety and tolerability
    Oertel, W.
    LeWitt, P.
    Grieger, F.
    Bauer, L.
    Boroojerdi, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 532 - 532
  • [27] Body composition in advanced-stage Parkinson's disease
    Petroni, ML
    Albani, G
    Bicchiega, V
    Baudo, S
    Vinci, C
    Montesano, A
    Izzo, G
    Bertocco, P
    Mazzotta, S
    Zorzetto, E
    Balzola, F
    Mauro, A
    ACTA DIABETOLOGICA, 2003, 40 (Suppl 1) : S187 - S190
  • [28] Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Masahiro Nomoto
    Yoshikuni Mizuno
    Tomoyoshi Kondo
    Kazuko Hasegawa
    Miho Murata
    Masahiro Takeuchi
    Junji Ikeda
    Takayuki Tomida
    Nobutaka Hattori
    Journal of Neurology, 2014, 261 : 1887 - 1893
  • [29] Safety and tolerability of rotigotine transdermal system in patients over 70 years with advanced Parkinson's disease
    Capecci, M.
    Andrenelli, E.
    Sordoni, E.
    Monsu, A. M.
    Di Biagio, L.
    Ceravolo, M. G.
    MOVEMENT DISORDERS, 2014, 29 : S136 - S136
  • [30] Ropinirole versus pramipexole as adjunctive therapy to levodopa in Parkinson's disease
    Barbato, L
    Cattaneo, C
    Monge, A
    Nordera, G
    MOVEMENT DISORDERS, 2002, 17 : S49 - S49
12345